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Major depression and spatial memory impairment are the most common comorbidities in patients 
with temporal lobe epilepsy (TLE). For these patients, treatment options are limited highlighting the 
need for innovative treatments such as Designer Receptors Exclusively Activated by Designer Drugs 
(DREADDs). Studies investigating the effect of DREADDs on these comorbidities are lacking.  
In the present study, we evaluated whether activation of hM4Di DREADDs with clozapine affects 
anhedonia (i.e. the inability to experience pleasure) and spatial memory in the intraperitoneal kainic 
acid (IPKA) rat model for TLE. 
 
Method 
Status epilepticus (SE) was elicited by i.p. kainic acid (KA) injections in male Sprague Dawley rats. A 
control group was injected with saline (SAL). Three months post-SE, animals received bilateral 
intrahippocampal adeno-associated viral vector injections (2x0.5µL) carrying the hM4Di DREADD or a 
SHAM construct, yielding four experimental groups: KA-DREADD (n=8), KA-SHAM (n=6), SAL-DREADD 
(n=5) and SAL-SHAM (n=5). Anhedonia was evaluated using the saccharin preference test (SPT) and 
the novel object test (NOL) to assess spatial memory impairment. Following hM4Di DREADDs 
activation by clozapine (0.1 mg/kg, s.c.), the SPT and NOL were repeated. 
 
Results 
The KA group showed a significant reduction in preference towards saccharin compared to the SAL 
group (66.25% vs 96.96% respectively, p<0.001). In the NOL, a trend towards spatial memory 
impairment was observed in the KA group. DREADDs activation with clozapine increased preference 




The IPKA rat model displays anhedonic-like behavior whereas enlargement of sample size is required 
for characterization of spatial memory impairment. Although activation of hM4Di DREADDs did not 
alter spatial memory, an increased preference towards saccharin was present in the IPKA rat model 
containing hM4Di DREADDs, suggesting a potential antidepressant effect. 
